Detalhe da pesquisa
1.
Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin.
Br J Cancer
; 113(12): 1687-93, 2015 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26633559
2.
Nibrin is a marker of clinical outcome in patients with advanced serous ovarian cancer treated in the phase III OVA-301 trial.
Gynecol Oncol
; 132(1): 176-80, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24211400
3.
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program.
BMC Cancer
; 13: 64, 2013 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23388156